BIO Mid-America Draws Biotech, Pharma and Investors.WASHINGTON -- This week, 325 biotechnology executives and investors gathered at the BIO Mid-America VentureForum to learn about the 58 presenting Midwest biotech companies and participate in workshops and plenary sessions Plenary session is a term often used in s to define the part of the conference when all members of all parties are in attendance.
These sessions may contain a broad range of content from Keynotes to Panel Discussions and are not necessarily related to a specific style of delivery. highlighting trends in the industry. The meeting was held in Milwaukee, Wis. on Sept. 24-26.
"BIO Mid-America VentureForum successfully brought together emerging biotech companies and investors to encourage greater investment in emerging new therapies for diseases," said BIO President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Jim Greenwood.
For the first time at BIO Mid-America, several of the world's largest pharmaceutical companies, including Abbott, Eli Lilly and Company Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company and one of the world's largest corporations. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States. , Procter & Gamble, and Pfizer Inc, provided corporate presentations sharing business development strategies and highlighting their focus on partnerships with emerging companies. BIO added these presentations to the program because of pharmaceutical companies' interest in reaching early stage companies, and their investors, for potential deal making.
"These presentations exemplify the growing trend of large cap pharmaceutical companies' commitment to identifying and partnering with seed and early-stage entrepreneurial companies," said Alan Eisenberg, executive vice president of emerging companies and business development at BIO.
The event featured presentation on biotech companies, a series of workshops on biotech trends and strategies, business development opportunities, and networking receptions. GE Healthcare's Michael J. Barber presented a keynote address keynote address
An opening address, as at a political convention, that outlines the issues to be considered. Also called keynote speech.
Noun 1. focused on GE's Early Health strategy to use technology and bio-science to transform healthcare through earlier diagnosis, information, intervention and ongoing monitoring of disease and disease indicators.
Partners for the 2007 conference include BioOhio, Colorado Bioscience Association, Illinois Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
Upcoming BIO Events BIO InvestorForum 2007 October 9-11, 2007 San Francisco, Calif. BIO-Europe 2007 International Partnering Conference November 12-14, 2007 Hamburg, Germany Pacific Rim Summit on Industrial Biotechnology and Bioenergy November 14-16, 2007 Honolulu, Hawaii 2008 BIO International Convention June 17-20, 2008 San Diego, Calif.
Visit www.bio.org for information on all upcoming events.
About BIO www.bio.org
BIO represents more than 1,100 biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , academic institutions, state biotechnology centers and related organizations across the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology Environmental biotechnology is when biotechnology is applied to and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation. products. BIO also produces the annual BIO International Convention, the world's largest gathering of the biotechnology industry.
About the BIO Mid-America VentureForum http://bma.bio.org
BIO Mid-America will feature presentations from up to 60 promising seed, early- and late-stage private biotech product and platform companies from the Midwest as well as presentations from leading North American North American
named after North America.
North American blastomycosis
see North American blastomycosis.
North American cattle tick
see boophilusannulatus. venture capital firms Name Location Founding date Managing Partners/Directors Specialty Capital managed
5AM Ventures Menlo Park, CA; Waltham, MA 2002 John Diekman, PhD (managing partner), Scott Rocklage, PhD (managing partner), Andrew Schwab (managing partner) life sciences $200M  in the life sciences field. Workshops and plenary sessions will be offered on trends in the biotech industry, with a special focus on key success factors for early-stage companies, research and development, market trends, and financing. In addition, there will be formal and informal networking opportunities with industry CEOs and venture capital leaders.